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A 46-year-old man with an eight-year medical history of diabetes and hypertension presented with 1 h of chest pain accompanied 
by ST elevation in leads II, III and AVF on an electrocardiogram. 
Coronary angiography revealed total occlusion of the proximal right 
coronary artery (RCA). The culprit lesion was successfully treated 
with implantation of a 3.5 mm × 33 mm sirolimus- eluting stent after 
predilation. A routine angiogram after six months revealed a complete 
fracture of the stent at the distal two-thirds portion accompanied by 
70% focal luminal narrowing (Figures 1A and 1B, and Video 1). The 
fracture was located at the centre of hinge motion of the RCA. 
Intravascular ultrasound showed intimal hyperplasia with a lumen area 
of 3.58 mm2 (arrowheads), a plaque area of 17.29 mm2 and an external 
elastic membrane area of 20.82 mm2 (Figure 1C). It was decided that 
this restenotic lesion would not be treated with an interventional 
procedure because the RCA territory showed poor viability on cardiac 
magnetic resonance imaging. Three years later, the patient was evalu-
ated with angiography because of newly developed chest pain. 
Surprisingly, angiography showed increased lumen diameter at the 
fracture site (Figure 1D and Video 2). Intravascular ultrasound also 
showed regression of intimal hyperplasia, with a lumen area of 
4.58 mm2 (arrowheads), a plaque area of 11.60 mm2 and an external 
elastic membrane area of 16.18 mm2 (Figure 1E).
Fracture of coronary drug-eluting stents is not rare and is occasion-
ally associated with restenosis (1). However, currently, there is no 
consensus on its treatment methods. The mechanism behind natural 
regression of intimal hyperplasia at the site of stent fracture in the 
present case is not clear. The present case suggests that not all rest-
enotic lesions associated with stent fractures require interventional 
treatment, but can remain free of events with regression of intimal 
hyperplasia.
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